Stay updated on Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.5 to v3.6.6, indicating a backend/template update rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-08-31T16:26:04.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.5, indicating an update to the page template used to render this study record. This change reflects a backend version upgrade rather than new study information.
    Difference
    0.0%
    Check dated 2026-08-10T07:30:10.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, representing a minor revision of the page's metadata. This update does not alter study content, eligibility criteria, or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-07-26T19:10:56.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.3, replacing the previous v3.6.2. This indicates a newer version of the study record.
    Difference
    0.0%
    Check dated 2026-07-05T05:00:14.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates a maintenance update to the site without altering the study content.
    Difference
    0.0%
    Check dated 2026-06-28T01:33:54.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The study page now explicitly notes that recruitment is no longer open. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment header, along with a site-wide Revision: v3.6.0 tag.
    Difference
    1.0%
    Check dated 2026-06-13T17:16:15.000Z thumbnail image

Stay in the know with updates to Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab With BRAF/MEK Inhibitors in Melanoma Clinical Trial page.